MAM
Seniority & Nobel Hygiene’s latest offering is for silvers with active lifestyle
NEW DELHI: Adult incontinence is a major health issue affecting millions of senior citizens across the world. In an effort to cater to the evolving needs of the elderly, Seniority and Nobel Hygiene have joined hands to launch a new range of adult diapers – Friends Premium Pants with a unique odour-lock technology and anti-bacterial core for added comfort.
Friends Premium Pants has been designed with exclusive features such as leak guards on both sides to enhance its absorption capacity for up to 10 hours. The pant-style diapers offer greater comfort and hygiene, and are the perfect solution for elders with light incontinence issues. Its unique features provide the freedom, dignity, and confidence to the elderly to lead an active lifestyle.
Seniority co-founder Tapan Mishra said, “Incontinence is not just a physiological issue but also a major mental health concern for the elderly and their caregivers. Our deep understanding of the consumers’ requirements, combined with the industry intelligence of Nobel Hygiene, has allowed us to introduce Friends Premium Pants. We are delighted with this collaboration since it strengthens our commitment to cater to the lifestyle needs of seniors and make them more mobile and independent.”
Nobel Hygiene VP- marketing and commerce Kartik Johari said, "Friends Diapers remains steadfast in our commitment to the silvers in India, and to ensure that they receive the best-in-class products for their azadi. Thus, when Seniority approached us to co-create an offering for their audience, it was the perfect meld of market and product. We are glad to offer a special collaboration product to serve the needs of even more silvers.”
Seniority has released several campaigns in order to reach out to its audience and create awareness about its products in the category.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
